期刊文献+
共找到28,871篇文章
< 1 2 250 >
每页显示 20 50 100
Research on the Threshold Effect of China’s Pharmaceutical Export Trade on Internal and External R&D Investment
1
作者 Qiao Jiahui Song Yu +1 位作者 Gong Jingran Chen Yuwen 《Asian Journal of Social Pharmacy》 2024年第2期135-146,共12页
Objective To study the threshold effect of export trade on internal and external R&D investment in China’s pharmaceutical industry,and to provide reference for some pharmaceutical enterprises to improve the inves... Objective To study the threshold effect of export trade on internal and external R&D investment in China’s pharmaceutical industry,and to provide reference for some pharmaceutical enterprises to improve the investment.Methods The panel data of pharmaceutical industry in 25 provinces and cities in China from 2009 to 2019 were selected to conduct empirical analysis by establishing a threshold regression model,and a better export trade interval was obtained.Results and Conclusion There is a threshold value for the effect of new product export on both internal and external R&D expenditures,and the threshold values are 845.2788 million yuan and 318.4198 million yuan,respectively.There is a single threshold effect of export trade on both internal and external R&D investment in China’s pharmaceutical industry,and the effect of export trade on internal and external R&D investment changes from negative to positive as the export trade develops from low to high. 展开更多
关键词 pharmaceutical industry threshold effect export trade r&d investment
下载PDF
Countermeasures and Suggestions for Strengthening Human Resource Management in China’s Pharmaceutical Industry
2
作者 Sun Yuyuan Wang Shuling 《Asian Journal of Social Pharmacy》 2024年第2期202-207,共6页
Objective To provide reference and enlightenment for the development of human resource management in China’s pharmaceutical industry and to put forward some suggestions to promote the further development of pharmaceu... Objective To provide reference and enlightenment for the development of human resource management in China’s pharmaceutical industry and to put forward some suggestions to promote the further development of pharmaceutical industry.Methods The method of literature review was used to analyze the current situation and existing problems of human resource management in China’s pharmaceutical industry.Results and Conclusion Only by continuously improving the human resource management skills and innovating management methods can pharmaceutical enterprises achieve long-term benefits with sustainable development.The formulation of human resource management strategy in pharmaceutical industry must be conducive to the realization of the business goals of enterprises.To achieve this overall goal,the human resources management department of enterprises must make the plan from a strategic perspective,formulate talent strategic planning which serves the overall strategic goal of the enterprise.As a result,human resource management will play an important role in the development of China’s pharmaceutical industry. 展开更多
关键词 pharmaceutical industry human resource management COUNTErMEASUrE
下载PDF
Digital Transformation Trend of the Pharmaceutical Distribution Industry in the Context of New Infrastructure in China
3
作者 Gan Xingzhi 《Asian Journal of Social Pharmacy》 2024年第2期159-167,共9页
Objective To study the pharmaceutical distribution industry against the background of new infrastructure construction since it is vital to the health and life of the public,and to offer some suggestions to further imp... Objective To study the pharmaceutical distribution industry against the background of new infrastructure construction since it is vital to the health and life of the public,and to offer some suggestions to further improve the industry quality and achieve industry upgrading.Methods The national strategies for new infrastructure as well as the underlying logic for enterprise digital transformation were analyzed to provide the outlook on the digital transformation trend of the pharmaceutical distribution industry.Results and Conclusion In the future,the pharmaceutical distribution industry shall transform the pattern,channel,management and control,and experience in the entire business chain in a digital way by focusing on connection efficiency,data efficiency and decision-making efficiency. 展开更多
关键词 pharmaceutical distribution digital transformation new infrastructure TrENd
下载PDF
Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China
4
作者 Qu Simeng Wang Shuling 《Asian Journal of Social Pharmacy》 2024年第1期81-88,共8页
Objective To study the profit model of Chinese pharmaceutical O2O enterprises.Methods A case study of three typical pharmaceutical O2O enterprises was conducted,and their profit models were compared.Results and Conclu... Objective To study the profit model of Chinese pharmaceutical O2O enterprises.Methods A case study of three typical pharmaceutical O2O enterprises was conducted,and their profit models were compared.Results and Conclusion The pharmaceutical O2O enterprises in China are divided into three categories according to the profit models.It is found that the current pharmaceutical O2O enterprises have problems such as simple profit model and low corporate profits.Based on these problems,it is recommended that relevant enterprises develop various business models to increase profit channels.Besides,they should establish and improve internal cost control systems. 展开更多
关键词 pharmaceutical O2O profit model case analysis
下载PDF
Research on the Status Quo and Countermeasures of Human Resource Management Outsourcing in China’s Pharmaceutical Enterprises
5
作者 Wang Jianing Wang Shuling 《Asian Journal of Social Pharmacy》 2024年第1期64-71,共8页
Objective To explore the current situation of human resource management outsourcing in China’s pharmaceutical enterprises,and to put forward some suggestions for enterprises and the government.Methods The current sit... Objective To explore the current situation of human resource management outsourcing in China’s pharmaceutical enterprises,and to put forward some suggestions for enterprises and the government.Methods The current situation of human resource management outsourcing in China’s pharmaceutical enterprises was analyzed through the method of literature research.Results and Conclusion At present,the status of human resource management outsourcing in China’s pharmaceutical companies is that the level of human resource outsourcing companies is not high,and there are no relevant industry norms and laws.The information asymmetry between pharmaceutical enterprises and outsourcing companies results in adverse selection and moral hazard.Besides,the different culture of pharmaceutical enterprises and outsourcing companies leads to inefficient communication between enterprises and employee.To solve these problems,the government should promote and improve industry norms and laws to regulate the market.In addition,enterprises should clarify the motivation for outsourcing and make good decision on the outsourcing content.Meanwhile,enterprises should strengthen communication with employees to eliminate employees’concerns. 展开更多
关键词 pharmaceutical enterprise human resource management outsourcing countermeasure research
下载PDF
石家庄市R&D经费投入现状分析与对策研究
6
作者 王燕 张陆行 李国强 《产业与科技论坛》 2024年第11期18-21,共4页
R&D经费投入强度,是国际上通用的衡量一个国家或者地区科技投入强度的重要指标,成为评价其科技实力、核心竞争力和创新程度的重要标准。本文在对石家庄市研发投入开展调研的基础上,对R&D经费投入开展总体分析、结构分析、横纵... R&D经费投入强度,是国际上通用的衡量一个国家或者地区科技投入强度的重要指标,成为评价其科技实力、核心竞争力和创新程度的重要标准。本文在对石家庄市研发投入开展调研的基础上,对R&D经费投入开展总体分析、结构分析、横纵向比较分析,找出存在的问题,提出加大政府对科研活动的支持、大力发展新兴产业、重视研发投入统计等对策与建议。 展开更多
关键词 r&d经费投入 科研活动 科技实力
下载PDF
云南省R&D经费投入结构动态研究 被引量:1
7
作者 张和平 钟翔 +1 位作者 段江涛 贺新华 《中国科技资源导刊》 2024年第1期92-99,共8页
为研究云南省“十二五”以来R&D经费投入结构变化,分析R&D经费投入现状,并与全国,东、中、西部地区及临近省份进行了对比;从资金来源和资金配置视角,运用Cobb-Douglas效用函数及其修正模型对R&D经费投入结构展开动态分析。... 为研究云南省“十二五”以来R&D经费投入结构变化,分析R&D经费投入现状,并与全国,东、中、西部地区及临近省份进行了对比;从资金来源和资金配置视角,运用Cobb-Douglas效用函数及其修正模型对R&D经费投入结构展开动态分析。结果表明:云南省R&D经费投入结构不尽合理,资金来源中政府资金占比较低且呈下降趋势,资金配置中基础研究和应用研究投入不足,与最优结构偏离程度较大。针对存在的问题,提出持续加大政府R&D经费投入力度、围绕产业链提升基础研究和应用研究比重的建议。 展开更多
关键词 r&d经费 政府r&d投入 资源配置 活动类型 云南省 Cobb-douglas效用函数
下载PDF
政府R&D资助对OFDI逆向绿色创新的影响机制研究 被引量:1
8
作者 韩先锋 刘娟 李勃昕 《运筹与管理》 CSCD 北大核心 2024年第1期158-164,共7页
应用中国分省区层面数据并采用面板门槛模型,实证考察了政府R&D资助影响OFDI逆向绿色创新的动态效应。研究发现,OFDI对国内绿色创新产生了显著的驱动效应,但这种影响呈现出明显的先负后正的“U”型动态演化特征;政府R&D资助会... 应用中国分省区层面数据并采用面板门槛模型,实证考察了政府R&D资助影响OFDI逆向绿色创新的动态效应。研究发现,OFDI对国内绿色创新产生了显著的驱动效应,但这种影响呈现出明显的先负后正的“U”型动态演化特征;政府R&D资助会正向调节OFDI逆向绿色创新溢出,且存在最适宜于OFDI逆向绿色创新的政府R&D资助区间(0.366,0.428],过高或过低强度的政府R&D资助均会在一定程度上造成OFDI逆向绿色创新的红利损失;政府R&D资助调节下OFDI对绿色创新的动态影响具有显著时空异质性,即在时空维度上存在“激励效应”与“挤出效应”交替演化的鲜明特征。 展开更多
关键词 政府r&d资助 对外直接投资 绿色创新
下载PDF
R&D资本化背景下我国TFP增长率再测算
9
作者 杜瑶 许永洪 《统计研究》 北大核心 2024年第1期33-45,共13页
研究与试验发展(R&D)资本对经济增长和科技创新作用日益凸显,但对于R&D资本的核算亟待完善。本文基于SNA2008和CSNA2016框架,将R&D支出作为资本形成,对我国各省份物质资本存量和R&D资本存量进行规范化测算,使用随机前... 研究与试验发展(R&D)资本对经济增长和科技创新作用日益凸显,但对于R&D资本的核算亟待完善。本文基于SNA2008和CSNA2016框架,将R&D支出作为资本形成,对我国各省份物质资本存量和R&D资本存量进行规范化测算,使用随机前沿分析法重新估算1991—2019年间的全要素生产率(TFP)增长率。研究发现:第一,我国R&D资本存量规模呈总体递增和地区聚集趋势;第二,1991—2019年间,我国广义TFP增长率年平均增幅为2.10%,对经济增长存在正向作用;第三,将TFP增长率分解为技术进步、前沿技术效率和规模效应,发现技术进步对TFP增长率的贡献最大,是推动我国TFP增长的主导力量,但却呈现逐年递减的趋势;第四,随着我国对R&D投入的不断增加与重视,R&D对我国广义TFP增长率的贡献呈现递增的趋势,R&D的贡献逐渐成为推动我国科技进步的主要力量。 展开更多
关键词 r&d资本化 r&d资本存量 TFP增长率 随机前沿分析
下载PDF
Evaluation of Phytochemical Contents and Antimicrobial Activities of Pandiaka heudelotii
10
作者 Ikenna Obiora Alaekwe Uche Eunice Ekpunobi +2 位作者 Vincent Ishmel Egbulefu Ajiwe Chinedu Chris Aguoma Jamilu Ahmad 《Advances in Biological Chemistry》 CAS 2024年第2期55-63,共9页
The work investigated the secondary metabolites present in different parts of the Pandiaka heudelotii plant harvested from Ezira, Orumba south local government area of Anambra state, southeastern Nigeria as well as th... The work investigated the secondary metabolites present in different parts of the Pandiaka heudelotii plant harvested from Ezira, Orumba south local government area of Anambra state, southeastern Nigeria as well as their antimicrobial activity. The objectives were to extract, determine the phytochemicals present, evaluate the antimicrobial potential and determine the zones of inhibition of the root, stem and leaf extracts of the plant. The emergence of antibiotics has decreased the spread and severity of a wide range of diseases. Plant extracts were tested for antibacterial and antifungal activities against Staphylococcus aureus, Escherichia coli, Proteus vulgaris, Streptococcus pyogenes, Bacillus subtelis, Pseudomonas aerogenes, Salmonella typhi, Aspergillus flavus, Aspergillus niger and Candida albicans. The zone of inhibition of extracts was compared with that of standard drugs like Erythromycin, Ciprofloxacin, Fulcin and Fluconazole. The result revealed the inhibition of bacterial and fungal growth with some test organisms. The microbial activity of the plant parts may be due to the presence of various secondary metabolites. The ethyl acetate extracts of Pandiaka heudelotii stood out with a minimum inhibitory concentration (MIC) range of 5 - 10 mg/mL and a minimum bactericidal concentration (MBC)/minimum fungicidal concentration (MFC) of 10 - 20 mg/ml against some test organisms. The plant can thus be worked upon to discover biologically active natural products that may serve as a prelude to the development of new pharmaceutical research undertakings. 展开更多
关键词 pharmaceuticals Secondary Metabolites ANTIBIOTICS Pandiaka heudelotii BACTErIA
下载PDF
2021年副省级城市R&D经费投入分析
11
作者 王春 王艳 吕海刚 《行政事业资产与财务》 2024年第4期34-36,共3页
2017—2021年,副省级城市的R&D经费投入都保持持续增长的态势。深圳的R&D经费投入在副省级城市中一直处于遥遥领先的地位,西安由于科研院所和高校众多,2017年R&D经费投入总量在副省级城市中排名第四,2021年排名第七,被资源... 2017—2021年,副省级城市的R&D经费投入都保持持续增长的态势。深圳的R&D经费投入在副省级城市中一直处于遥遥领先的地位,西安由于科研院所和高校众多,2017年R&D经费投入总量在副省级城市中排名第四,2021年排名第七,被资源禀赋相似的南京、成都、武汉等城市超越。西安由于GDP总量不高,R&D经费投入强度一直保持在5%左右,2020年被深圳反超。基于数据的可获得性,本文从2021年副省级城市的R&D经费投入总量、R&D经费投入强度等方面进行解读和分析,并结合分析结果提出相关建议,以供参考。 展开更多
关键词 副省级城市 r&d经费投入总量 r&d经费投入强度
下载PDF
基于DRG支付的药事管理干预对基层医院静脉输液合理使用的影响
12
作者 葛欣 刘平 +2 位作者 张士伟 朱妍莹 程慎令 《中国药业》 CAS 2024年第2期6-10,共5页
目的促进医院合理使用静脉输液。方法基于疾病诊断相关分组(DRG)支付进行药事管理干预,干预时间为2021年10月至12月,干预手段包括加强宣传教育培训,梳理静脉输液药品品种与疾病谱,制订病种相应临床路径,增加输液处方专项点评内容,将不... 目的促进医院合理使用静脉输液。方法基于疾病诊断相关分组(DRG)支付进行药事管理干预,干预时间为2021年10月至12月,干预手段包括加强宣传教育培训,梳理静脉输液药品品种与疾病谱,制订病种相应临床路径,增加输液处方专项点评内容,将不合理处方开具情况纳入绩效考核,开展信息系统管控。通过医院信息系统与合理用药软件提取医院门/急诊与住院部2021年1月至9月(药事管理干预前)与2022年1月至9月(药事管理干预后)的病例资料,分析干预前后全部处方及含抗菌药物、含中药注射剂、含激素类药物(或辅助药品)处方中静脉输液相关指标及住院病例DRG相关药事指标。结果静脉输液相关指标,与干预前比较,干预后的门/急诊患者总体及不同类型药物静脉输液率(以人次、处方数计)均显著降低(P<0.01),住院患者除抗菌药物外的静脉输液率(以人次计)均显著降低(P<0.01);门/急诊与住院患者药品使用金额均不同幅度降低;门/急诊患者处方退回修改率显著升高(3.54%比2.41%,P<0.01);患者对静脉输液服务的总满意度显著升高(94.20%比73.20%,P<0.01)。DRG相关指标,与干预前比较,干预后的住院患者DRG总权重、病例组合指数(CMI)及基本药物使用金额占比均升高,费用消耗指数、时间消耗指数和患者次均费用均降低,且患者死亡率及静脉输液药品结构比、辅助药品结构比、次均药费、次均辅助药费均降低。结论该药事管理模式显著降低了静脉输液率,并提高了医院合理用药水平,减少了患者的就医费用,并提高了患者满意度,继而整体提升了该院的医疗服务能力。 展开更多
关键词 drG支付 基层医院 药事管理 静脉输液率 合理用药
下载PDF
Online pharmaceutical process analysis of Chinese medicine using a miniature mass spectrometer: Extraction of active ingredients as an example 被引量:1
13
作者 Wangmin Hu Junling Hou +4 位作者 Wenjing Liu Xuan Gu Yulei Yang Hongcai Shang Mei Zhang 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2023年第5期535-543,共9页
The automation of traditional Chinese medicine(TCM)pharmaceuticals has driven the development of process analysis from offline to online.Most of common online process analytical technologies are based on spectroscopy,... The automation of traditional Chinese medicine(TCM)pharmaceuticals has driven the development of process analysis from offline to online.Most of common online process analytical technologies are based on spectroscopy,making the identification and quantification of specific ingredients still a challenge.Herein,we developed a quality control(QC)system for monitoring TCM pharmaceuticals based on paper spray ionization miniature mass spectrometry(mini-MS).It enabled real-time online qualitative and quantitative detection of target ingredients in herbal extracts using mini-MS without chromatographic separation for the first time.Dynamic changes of alkaloids in Aconiti Lateralis Radix Praeparata(Fuzi)during decoction were used as examples,and the scientific principle of Fuzi compatibility was also investigated.Finally,the system was verified to work stably at the hourly level for pilot-scale extraction.This mini-MS based online analytical system is expected to be further developed for QC applications in a wider range of pharmaceutical processes. 展开更多
关键词 Process analytical technology TCM pharmaceuticals Miniature mass spectrometry Online analysis
下载PDF
Research on Corporate Social Responsibility Evaluation Based on Improved CRITIC-TOPSIS—A Case Study of Listed Companies in China’s Pharmaceutical Distribution Industry 被引量:1
14
作者 Lili Liu Yingyu Wu Jingxian Liu 《Open Journal of Applied Sciences》 CAS 2023年第5期704-719,共16页
Corporate social responsibility (CSR) has garnered considerable attention from countries, institutions, enterprises and social groups. However, the lack of research on CSR evaluation system for industries has impeded ... Corporate social responsibility (CSR) has garnered considerable attention from countries, institutions, enterprises and social groups. However, the lack of research on CSR evaluation system for industries has impeded its development and construction across various industries. Therefore, given the close association of pharmaceutical distribution enterprises with personal health, there exists a pressing need to explore the CSR in this domain. This paper establishes a CSR evaluation index system for pharmaceutical distribution enterprises, employing a combination of documentary analysis and in-depth interviews. This index system comprises 7 CSR criterion layers (e.g., responsible governance and employee responsibility) and 56 index layers. 25 listed companies in China’s pharmaceutical distribution industry are chosen as research objects, and this study also establishes an evaluation model for the CSR of pharmaceutical distribution companies through the improved Criteria Importance Though Intercrieria Correlation (CRITIC) method combined with The Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) method. The empirical analysis reveals that the responsible governance criterion layer and the social development criterion layer demonstrate the best performance, while the supplier, customer and patient responsibility criterion layer exhibit the worst performance. 展开更多
关键词 pharmaceutical distribution Enterprises Corporate Social responsibility Evaluation System Improved CrITIC-TOPSIS
下载PDF
数字化转型、R&D投入与企业创新绩效
15
作者 光晖 刘颖 《现代管理科学》 北大核心 2024年第3期187-195,共9页
数字化转型作为促进企业高质量发展、落实建设数字中国的重要举措,对于加快企业科技成果转化速度、提升企业创新绩效具有重要作用。以2012—2022年1462家沪深A股上市公司为主要研究对象,采用基准回归模型和中介模型,对数字化转型、新质... 数字化转型作为促进企业高质量发展、落实建设数字中国的重要举措,对于加快企业科技成果转化速度、提升企业创新绩效具有重要作用。以2012—2022年1462家沪深A股上市公司为主要研究对象,采用基准回归模型和中介模型,对数字化转型、新质生产力和企业创新绩效三者之间关系进行深入分析。研究发现:数字化转型对企业创新绩效具有显著提升效应,且经过稳健性检验之后这一结论仍然成立。机制检验结果证实,R&D投入在数字化转型与企业创新绩效之间发挥重要中介作用。异质性分析发现,数字化转型对国有企业、大型企业及高新技术企业的创新绩效提升效应更强。据此,提出打造数字化商业模式,加速推动数字化转型;加大R&D投入力度,激发企业创新研发活力;实施差异化发展战略,提升企业创新绩效等建议。 展开更多
关键词 数字化转型 技术创新 企业创新绩效 r&d投入
下载PDF
创新驱动发展战略下R&D资本化的统计核算
16
作者 刘浩 高跃伟 《时代经贸》 2024年第6期60-63,共4页
国家统计局根据国际最新国民经济核算体系对研发支出的核算方法进行改革,在新核算标准下,R&D作为固定资产计入GDP,此举对于我国国民经济核算体系的升级具有重要意义。本文对我国R&D核算方法调整的动因以及在新核算模式下R&... 国家统计局根据国际最新国民经济核算体系对研发支出的核算方法进行改革,在新核算标准下,R&D作为固定资产计入GDP,此举对于我国国民经济核算体系的升级具有重要意义。本文对我国R&D核算方法调整的动因以及在新核算模式下R&D应当依据怎样的标准进行核算做出了相应分析。研究发现,R&D支出资本化的核算会增大经济总量,但也存在“研发泡沫”和因研发的正外部性而低估R&D支出等风险。因此,为规避风险和避免R&D支出低估以及合理推进核算体系升级,应结合我国国情,加大研发支出的核算力度及相关研究的投入,并建立具有中国特色的R&D卫星账户体系。 展开更多
关键词 r&d核算 资本化 GdP统计核算
下载PDF
How R&D investment promotes green technology innovation in the context of digitalization?-An empirical analysis based on provincial panel data
17
作者 LIU Jie LI Zhi-hui WEI Fang-xin 《Ecological Economy》 2024年第1期39-52,共14页
Green technology innovation is an important driving force and source to promote my country’s high-quality development,and it is the core path to achieve sustainable development.This paper uses my country’s provincia... Green technology innovation is an important driving force and source to promote my country’s high-quality development,and it is the core path to achieve sustainable development.This paper uses my country’s provincial panel data from 2016 to 2019 to study the impact mechanism of R&D investment on green technology innovation,and introduces the level of digitization,using the panel threshold model to discuss its role in the impact mechanism of R&D investment on green technology innovation.The study found that when the level of digitalization in a region is low,increasing R&D investment does not necessarily improve the ability of green technology innovation;when the level of digitalization is relatively high,R&D investment has a positive role in promoting green technology innovation.Therefore,it is necessary to improve policies to encourage enterprises to increase investment in research and development;at the same time,it is necessary to promote the coordinated development of digital foundation,digital investment,digital literacy,digital economy and digital application,and promote the deep integration of digitalization and green technology innovation. 展开更多
关键词 green technology innovation r&d investment digital level panel model
下载PDF
科创能力持续提升创 新潜能仍需激发——2022年浙苏粤沪规模以上工业R&D活动的比较分析
18
作者 吴琼 《统计科学与实践》 2024年第4期13-15,共3页
工业作为实体经济的支柱产业,是推动经济高质量发展的基础和关键。科技创新是引领工业高质量发展的强大驱动力。本文通过比较浙江、江苏、广东、上海三省一市规模以上工业企业R&D活动的发展情况,分析浙江与兄弟省(市)之间的优势和差... 工业作为实体经济的支柱产业,是推动经济高质量发展的基础和关键。科技创新是引领工业高质量发展的强大驱动力。本文通过比较浙江、江苏、广东、上海三省一市规模以上工业企业R&D活动的发展情况,分析浙江与兄弟省(市)之间的优势和差距,提出激发企业主体活力加大科技创新投入、强化政府引导带动突出创新要素保障、发挥市场导向作用推动科技成果转化等建议,以期为浙江科技创新引领工业高质量发展提供有益借鉴。 展开更多
关键词 工业 r&d活动 科技创新
下载PDF
基于Tobit模型的河南省R&D投入产出影响因素分析
19
作者 王新 《河南科技》 2024年第10期144-148,共5页
【目的】科技创新能力是地区综合实力的重要标志之一,科学地识别影响科技资源投入产出的因素,是实现经济跨越式发展和可持续发展的关键。【方法】基于Tobit模型对近十年河南省R&D投入产出面板数据进行相关检验,分析得出各变量对河南... 【目的】科技创新能力是地区综合实力的重要标志之一,科学地识别影响科技资源投入产出的因素,是实现经济跨越式发展和可持续发展的关键。【方法】基于Tobit模型对近十年河南省R&D投入产出面板数据进行相关检验,分析得出各变量对河南省R&D投入产出产生的不同影响。【结果】企业研发机构投入和高水平人才比例与河南省R&D投入产出效率呈显著正相关,而政府支持力度和对外开放程度则对R&D投入产出效率的作用不显著。【结论】建议河南省通过转换政府职能、注重人才引进、加强对外交流、改善区域环境等方式,优化R&D投入产出,更好地提升科技效能。 展开更多
关键词 r&d 影响因素 TOBIT模型
下载PDF
粤港澳大湾区企业R&D活动特征研究
20
作者 雷钦礼 《统计理论与实践》 2024年第3期11-20,共10页
基于上市公司数据,对粤港澳大湾区企业R&D活动的行业、规模、经济类型以及研发效益的时滞特征进行研究。发现的典型事实有:(1)企业R&D活动具有明显的行业特征,高强度的研发企业主要聚集于信息通信技术(ICT)、医药制造、仪器仪... 基于上市公司数据,对粤港澳大湾区企业R&D活动的行业、规模、经济类型以及研发效益的时滞特征进行研究。发现的典型事实有:(1)企业R&D活动具有明显的行业特征,高强度的研发企业主要聚集于信息通信技术(ICT)、医药制造、仪器仪表和设备制造等高新技术行业;(2)企业研发活动与企业规模有关,大型企业的研发规模大,但是小型企业研发强度最高,大型企业最低;(3)经济类型不同企业的研发投入强度没有显著差异,长期以来认为“国有企业研发强度和效率不如民营企业”的断言不符合实际;(4)企业研发强度与自身经营状况联系密切,盈利能力越强的企业R&D投入强度通常越高,盈利不佳的企业通常难以进行高强度的研发;(5)企业R&D研发效益的产生往往具有相当长的时滞,ICT行业中软件服务业研发效益的产生通常需要两年的滞后期,硬件设备制造业通常在五年以上。为促使企业持续加大R&D投入,尽快实现将粤港澳大湾区建成全球科技创新高地和新兴产业重要策源地的目标,一方面要大力培育企业经营者的企业家精神,另一方面应进一步改革税制,降低制造业增值税税率,增强企业的盈利能力和持续加大研发投入强度的能力。 展开更多
关键词 粤港澳大湾区 企业r&d 研发强度 研发效益
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部